|4Feb 3, 2:41 PM ET

Creem Mitchell 4

4 · Clinigence Holdings, Inc. · Filed Feb 3, 2021

Insider Transaction Report

Form 4
Period: 2021-01-28
Transactions
  • Award

    Director Stock Option (right to buy)

    2021-01-28$1.61/sh+45,000$72,450130,120 total
    Exercise: $1.61From: 2021-01-28Exp: 2028-01-28Common Stock (45,000 underlying)
Holdings
  • Common Stock

    31,746
Footnotes (1)
  • [F1]Quarterly 25% ,fully vested upon change in control, fully vested upon closing of merger.

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT